Purdue Pharma secured court approval for a $125 million settlement with McKinsey & Co. to resolve claims related to the ...
A federal judge criminally sentenced OxyContin-maker Purdue Pharma over its role in the opioid crisis, ahead of upcoming ...
Shutting down Purdue Pharma and replacing it with the nonprofit Knoa Pharma was perhaps the most innovative aspect of ...
By Dietrich Knauth NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its ...
Type to search articles, cases, and authors. Press ↵ to view all results. The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, ...
Nearly 140,000 people filed claims against the company for the harm they said its drugs caused. Fewer than half of them will get any compensation.
NEW YORK, April 9 (Reuters) - Consulting firm McKinsey & Co has agreed to contribute $125 million to Purdue Pharma's bankruptcy settlement, resolving potential legal claims over advice it provided to ...
OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the public interest under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results